Lassa fever is a viral illness endemic to West Africa that is transmitted to humans from contact with the multimammate rat. The document outlines the virus, transmission, symptoms, diagnosis and treatment of Lassa fever. It is most commonly spread through contact with urine or droppings from infected rats, which can enter the body through inhalation or ingestion. Person-to-person transmission is also possible. Supportive care and the antiviral drug ribavirin are used to treat the illness. Prevention focuses on reducing contact with rats and proper isolation of infected individuals.
The document summarizes Nigeria's 2016 Lassa fever epidemic. It describes the epidemiology and transmission of Lassa virus, symptoms and treatment of Lassa fever, and the response efforts. Key points include: (1) Lassa fever is endemic in West Africa and causes annual outbreaks in Nigeria, with the multimammate mouse being the primary host; (2) person-to-person transmission can occur in hospitals lacking infection control; (3) the case fatality rate was 1% historically but rose to 34.31% in the 2016 Nigeria outbreak; (4) supportive care and ribavirin treatment improve survival rates.
Lassa fever is a viral hemorrhagic fever caused by the Lassa virus and transmitted by rodents. It is endemic in West Africa, with an estimated 100,000-300,000 cases and 5,000 deaths annually. There is currently an outbreak in Nigeria affecting 12 states and 397 cases, resulting in 40 deaths so far. Clinical signs include gradual fever, headache, bleeding, and neck swelling. Diagnosis involves ELISA and PCR tests, and treatment is supportive care and the antiviral drug ribavirin. Preventing transmission involves avoiding contact with infected rodents and person-to-person spread through medical settings.
A simple presentation on the Lassa fever endemic in Nigeria - from its first discovery in a town called Lassa in northeastern Nigeria, the mode of transmission, to the control and prevention measures that can be applied to curbing the spread of the virus. Suitable for rural sensitization.
Excerpt from CDC -- [Signs & symptoms]
Signs and symptoms of Lassa fever typically occur 1-3 weeks after the patient comes into contact with the virus. For the majority of Lassa fever virus infections (approximately 80%), symptoms are mild and are undiagnosed. Mild symptoms include slight fever, general malaise and weakness, and headache. In 20% of infected individuals, however, disease may progress to more serious symptoms including hemorrhaging (in gums, eyes, or nose, as examples), respiratory distress, repeated vomiting, facial swelling, pain in the chest, back, and abdomen, and shock. Neurological problems have also been described, including hearing loss, tremors, and encephalitis. Death may occur within two weeks after symptom onset due to multi-organ failure.
The most common complication of Lassa fever is deafness. Various degrees of deafness occur in approximately one-third of infections, and in many cases hearing loss is permanent. As far as is known, severity of the disease does not affect this complication: deafness may develop in mild as well as in severe cases.
Approximately 15%-20% of patients hospitalized for Lassa fever die from the illness. However, only 1% of all Lassa virus infections result in death. The death rates for women in the third trimester of pregnancy are particularly high. Spontaneous abortion is a serious complication of infection with an estimated 95% mortality in fetuses of infected pregnant mothers.
Because the symptoms of Lassa fever are so varied and nonspecific, clinical diagnosis is often difficult. Lassa fever is also associated with occasional epidemics, during which the case-fatality rate can reach 50% in hospitalized patients.
The document summarizes the 1969 outbreak of Lassa fever that originated in Nigeria. It describes how the American missionary nurse Laura Wine became the first known case and infected the nurse Charlotte Shaw who cared for her. Their deaths prompted an investigation that led to the discovery of the Lassa virus. The virus is endemic in West African countries and transmitted from rodents to humans. It can also spread between humans. The document provides details on the epidemiology, clinical presentation, diagnosis and treatment of Lassa fever.
Lassa fever is an acute viral hemorrhagic fever caused by the Lassa virus. It is endemic to West Africa, where it is spread through contact with the urine or feces of the multimammate mouse host. Common symptoms include fever, weakness, facial swelling, vomiting, and bleeding. Diagnosis involves virus isolation from blood or tissue samples. Treatment consists of ribavirin antiviral therapy. Prevention focuses on rodent control and avoiding contact with infected materials. The mortality rate can be over 50% without treatment but is reduced to 5-10% with early ribavirin administration.
Lassa fever aka Lassa hemorrhagic fever is caused by lassa virus and is a Zoonotic disease. It is epidemic in Nigeria, Sierra Leone and Liberia.
Limiting direct contact between humans and rodents can help prevent this disease.
This document summarizes a seminar presentation on Lassa fever given by Dr. D.C. Briggs. It begins with an introduction covering viral hemorrhagic fevers in general and key characteristics of Lassa fever. It then discusses the epidemiology of Lassa fever, including its reservoir, transmission, and recent outbreaks in Nigeria. The document outlines the pathogenesis, clinical features, case definition, differential diagnosis, complications and management of Lassa fever cases. It concludes with the standard operating procedures for managing suspected Lassa fever cases at UPTH.
Lassa fever is a viral hemorrhagic fever endemic to parts of West Africa that is transmitted to humans from multimammate rats and can also spread between humans; it causes a range of symptoms from mild to severe and death in around 1/5 of cases without treatment, and treatment involves supportive care and the antiviral drug ribavirin which is most effective when given early.
Lassa fever is caused by the Lassa virus and is spread chiefly from rodents to humans. It was first discovered in Nigeria and is highly prevalent in West African countries, where an estimated 300-500,000 cases and 5,000 deaths occur annually. Symptoms include fever, headache, muscle pain and bleeding. Transmission occurs through contact with infected rodent excreta or bodily fluids or inhalation of aerosolized viruses. Prevention focuses on eliminating rodents and maintaining clean households and personal hygiene. While there is no cure, early diagnosis and treatment can reduce mortality.
Lassa fever is a viral hemorrhagic illness transmitted to humans through contact with the urine or feces of infected Mastomys rats. It is endemic in parts of West Africa, with 100,000-300,000 infections estimated annually. Symptoms can include bleeding, abdominal pain, and fever. Treatment involves supportive care and the antiviral ribavirin if given early. Prevention focuses on proper food storage, hygiene practices, and rodent control to avoid exposure to infected rats.
Malaria is caused by parasites of the Plasmodium type, which are transmitted via the bites of infected Anopheles mosquitoes. The parasites multiply in the liver and then infect red blood cells. Symptoms of malaria include fever, chills, and flu-like illness. Malaria most commonly occurs in subtropical and tropical areas of Africa, Asia, and South America. While the disease can be treated with antimalarial drugs, prevention through mosquito bite avoidance and antimalarial prophylaxis is most effective.
Malaria epidemiology, clinical features & treatmentDr. Animesh Gupta
?
Malaria is a protozoal disease caused by infection with
parasites of the genus Plasmodium and transmitted by
certain species of infected female Anopheles mosquito.
Lassa fever is caused by the Lassa virus and is endemic in parts of West Africa. It is primarily transmitted to humans via contact with the urine or feces of infected Mastomys rodents. Person-to-person transmission can also occur. Most cases are mild, but severe cases can involve bleeding, shock, and death in 15-30% of patients. Diagnosis involves virus detection via PCR or serologic testing for antibodies. Treatment consists of supportive care and the antiviral ribavirin.
Malaria PRESENATION AT NEW YOR MEDICAL COLLEGE AKSHAT JAIN akshatusa
?
The document provides information on malaria, including:
1) Malaria is caused by a parasite transmitted through mosquito bites and remains a serious problem in parts of Africa and Asia.
2) Symptoms can include fever, chills, vomiting, and in severe cases seizures or coma.
3) Diagnosis is made through examination of blood smears under a microscope to identify the malaria parasite, with treatment depending on the identified parasite species.
The lecture gives concise review about the main four groups of viruses causing hemorrhagic fever i.e. Flavivirues, Filoviruses, Arenaviruses and Bunyaviruses.
The document discusses SARS, MERS, and COVID-19. It describes the viruses' morphology, transmission, clinical manifestations, diagnosis, treatment and prevention. SARS was identified in 2003 in China and spread to 29 countries. MERS was first reported in 2012 in Saudi Arabia. COVID-19 spreads via droplets and contact. Symptoms range from fever and cough to difficulty breathing. Diagnosis involves antigen detection, antibody testing, cell culture and RT-PCR. There are no specific treatments, but prevention includes isolation, handwashing and travel restrictions. Vaccines are currently under trial.
Leptospirosis is a bacterial disease caused by Leptospira bacteria that can infect both humans and animals. It is transmitted through contact with water or soil contaminated by the urine of infected animals. Common symptoms include fever, headache, muscle aches, vomiting, and jaundice. The incubation period is usually 10 days. Diagnosis is confirmed through lab tests of body fluids and tissues. Treatment involves antibiotics like penicillin or doxycycline. Prevention relies on vaccination of animals, proper sanitation, and health education.
Rickettsiae are intracellular bacteria transmitted by ticks, mites, fleas or lice. Rickettsial infections cause fever, rash, and enlargement of organs
The document provides information about malaria, including:
1. Malaria is caused by parasites that are transmitted via mosquito bites and infect red blood cells, multiplying and breaking cells open to infect more.
2. It is a major health problem in tropical and subtropical regions. The most deadly form is caused by P. falciparum.
3. Symptoms include flu-like fever, headache, vomiting, and can progress to seizures, coma, or organ failure if severe. Pregnant women and their fetuses are particularly at risk.
Leptospirosis is a zoonotic disease caused by Leptospira interrogans bacteria. It has an incubation period ranging from 7-19 days with an average of 10 days. People can contract it through contact with flood waters or soil contaminated by the urine of infected animals like rats. Clinical manifestations include fever, muscle pain, headache, and potentially liver or kidney failure in severe cases. Diagnosis involves examining blood and CSF during the first week or urine on the 10th day. It is treated with antibiotics like penicillin prescribed by a physician.
Stigma & discrimination associated with hivaidsliyew
?
The document discusses stigma and discrimination associated with HIV/AIDS. It defines stigma as a negative attribute that reduces a person's status, and discrimination as unfair treatment based on real or perceived HIV status. Several forms of stigma are outlined, including physical isolation, social exclusion, verbal insults, and institutional barriers like loss of employment or housing. Stigma stems from lack of HIV knowledge and moral judgments about transmission. It can prevent people from seeking testing or care, and undermine prevention and treatment efforts. Addressing HIV-related stigma is important for achieving public health goals.
Malaria is a protozoal disease transmitted through the bites of infected female Anopheles mosquitoes. In 2016, there were an estimated 216 million cases of malaria worldwide, with the majority occurring in Africa. Symptoms vary depending on the Plasmodium species and include fever, chills, and flu-like illness. Diagnosis is typically made through blood smears, antigen testing, or PCR. Treatment involves antimalarial medications such as chloroquine or artemisinin-based combination therapies depending on the species and severity of illness. Prevention strategies include mosquito control measures and chemoprophylaxis for travelers. Drug and insecticide resistance present ongoing challenges to malaria elimination efforts.
The document summarizes information about Ebola virus hemorrhagic fever and Lassa virus hemorrhagic fever. It describes the etiology, epidemiology, signs and symptoms, diagnosis, treatment and prevention of the two viral hemorrhagic fevers. Ebola virus causes a severe multisystem disease in humans characterized by fever, headache and bleeding. Lassa fever is endemic in West Africa and transmitted from rodents to humans, causing fever, bleeding and organ dysfunction. Treatment involves supportive care and the antiviral drug ribavirin.
This document discusses viral hemorrhagic fever (VHF), specifically Lassa fever. It defines VHF and notes that Lassa fever, caused by the Lassa virus, is endemic in parts of West Africa. The virus is transmitted from rodents to humans and then through human contact. Symptoms can range from mild to severe. Diagnosis involves ELISA, PCR and immunohistochemistry. Treatment for Lassa fever involves supportive care and the antiviral drug ribavirin. Prevention focuses on avoiding contact with rodents, proper food storage, hygiene and use of PPE during potential human exposures.
(1) Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Septic shock is persisting hypotension requiring vasopressors and elevated lactate levels despite fluid resuscitation. Organ dysfunction is identified as an acute change in total SOFA score ¡Ý2 points due to infection.
(2) Laboratory diagnosis of sepsis involves blood cultures, biomarkers like PCT, CRP, lactate, cytokines and invasive fungal biomarkers like galactomannan and beta-D-glucan. Hematological parameters and newer techniques like MALDI-TOF and multiplex PCR are also used. Blood cultures remain the gold standard but are often culture negative
Typhoid fever is caused by the Salmonella typhi bacteria and spreads through contaminated food or water. It causes fever and systemic infection. Diagnosis involves blood or stool cultures and serologic testing. Treatment consists of antibiotics like fluoroquinolones for 2 weeks. Prevention involves food and water safety as well as vaccination for travel to areas where typhoid is common.
Dengue fever is a mosquito-borne tropical disease caused by the dengue virus. It is characterized by fever, headache, muscle and joint pains, and a skin rash. Some cases develop into life-threatening dengue hemorrhagic fever or dengue shock syndrome. It occurs widely in tropical areas and an estimated 50 million infections occur annually. The disease progresses through febrile, critical, and recovery phases. During the critical phase, increased capillary permeability can lead to life-threatening plasma leakage and shock.
The document discusses Ebola virus disease (EVD), also known as Ebola hemorrhagic fever. It first appeared in Africa in 1976 and causes severe bleeding and organ failure in humans and nonhuman primates. The virus spreads through direct contact with body fluids of infected individuals or contaminated environments. While there is no approved vaccine or treatment, prevention focuses on isolation of patients, medical staff training in infection control, safe burials, and avoiding contact with high-risk animals like bats that may carry the virus. The document provides details on the virus's pathogenesis, symptoms, subtypes, transmission methods, and the challenges it poses given its rapid multiplication and ability to evade immune responses.
Lassa fever is an acute viral illness endemic to West Africa that is caused by the Lassa virus. It is primarily transmitted to humans via contact with the urine or feces of the multimammate rat, which is the virus's natural host. The presentation outlines key details about the epidemiology, transmission, symptoms, management, and prevention of Lassa fever. Prevention focuses on avoiding contact with infected rats and properly disposing of or sterilizing contaminated items to limit human exposure to the virus.
This newsletter provides information on HIFASS' activities from fiscal year 2015. It discusses HIFASS completing the Safe Pregnancy Project in Benue State, which involved advocacy, identifying and training mentor mothers, peer sessions to mobilize pregnant women for services, and creating community-based organizations. It also summarizes HIFASS' participation in various conferences and meetings with other organizations regarding health initiatives in Africa, including an Ebola vaccine study in Abuja and a scientific training symposium in the US. Finally, it discusses LOPIN-3 organizing a performance review meeting and HIFASS participating in a forum with other CSOs implementing health programs in FCT.
Lassa fever is caused by the Lassa virus and is spread chiefly from rodents to humans. It was first discovered in Nigeria and is highly prevalent in West African countries, where an estimated 300-500,000 cases and 5,000 deaths occur annually. Symptoms include fever, headache, muscle pain and bleeding. Transmission occurs through contact with infected rodent excreta or bodily fluids or inhalation of aerosolized viruses. Prevention focuses on eliminating rodents and maintaining clean households and personal hygiene. While there is no cure, early diagnosis and treatment can reduce mortality.
Lassa fever is a viral hemorrhagic illness transmitted to humans through contact with the urine or feces of infected Mastomys rats. It is endemic in parts of West Africa, with 100,000-300,000 infections estimated annually. Symptoms can include bleeding, abdominal pain, and fever. Treatment involves supportive care and the antiviral ribavirin if given early. Prevention focuses on proper food storage, hygiene practices, and rodent control to avoid exposure to infected rats.
Malaria is caused by parasites of the Plasmodium type, which are transmitted via the bites of infected Anopheles mosquitoes. The parasites multiply in the liver and then infect red blood cells. Symptoms of malaria include fever, chills, and flu-like illness. Malaria most commonly occurs in subtropical and tropical areas of Africa, Asia, and South America. While the disease can be treated with antimalarial drugs, prevention through mosquito bite avoidance and antimalarial prophylaxis is most effective.
Malaria epidemiology, clinical features & treatmentDr. Animesh Gupta
?
Malaria is a protozoal disease caused by infection with
parasites of the genus Plasmodium and transmitted by
certain species of infected female Anopheles mosquito.
Lassa fever is caused by the Lassa virus and is endemic in parts of West Africa. It is primarily transmitted to humans via contact with the urine or feces of infected Mastomys rodents. Person-to-person transmission can also occur. Most cases are mild, but severe cases can involve bleeding, shock, and death in 15-30% of patients. Diagnosis involves virus detection via PCR or serologic testing for antibodies. Treatment consists of supportive care and the antiviral ribavirin.
Malaria PRESENATION AT NEW YOR MEDICAL COLLEGE AKSHAT JAIN akshatusa
?
The document provides information on malaria, including:
1) Malaria is caused by a parasite transmitted through mosquito bites and remains a serious problem in parts of Africa and Asia.
2) Symptoms can include fever, chills, vomiting, and in severe cases seizures or coma.
3) Diagnosis is made through examination of blood smears under a microscope to identify the malaria parasite, with treatment depending on the identified parasite species.
The lecture gives concise review about the main four groups of viruses causing hemorrhagic fever i.e. Flavivirues, Filoviruses, Arenaviruses and Bunyaviruses.
The document discusses SARS, MERS, and COVID-19. It describes the viruses' morphology, transmission, clinical manifestations, diagnosis, treatment and prevention. SARS was identified in 2003 in China and spread to 29 countries. MERS was first reported in 2012 in Saudi Arabia. COVID-19 spreads via droplets and contact. Symptoms range from fever and cough to difficulty breathing. Diagnosis involves antigen detection, antibody testing, cell culture and RT-PCR. There are no specific treatments, but prevention includes isolation, handwashing and travel restrictions. Vaccines are currently under trial.
Leptospirosis is a bacterial disease caused by Leptospira bacteria that can infect both humans and animals. It is transmitted through contact with water or soil contaminated by the urine of infected animals. Common symptoms include fever, headache, muscle aches, vomiting, and jaundice. The incubation period is usually 10 days. Diagnosis is confirmed through lab tests of body fluids and tissues. Treatment involves antibiotics like penicillin or doxycycline. Prevention relies on vaccination of animals, proper sanitation, and health education.
Rickettsiae are intracellular bacteria transmitted by ticks, mites, fleas or lice. Rickettsial infections cause fever, rash, and enlargement of organs
The document provides information about malaria, including:
1. Malaria is caused by parasites that are transmitted via mosquito bites and infect red blood cells, multiplying and breaking cells open to infect more.
2. It is a major health problem in tropical and subtropical regions. The most deadly form is caused by P. falciparum.
3. Symptoms include flu-like fever, headache, vomiting, and can progress to seizures, coma, or organ failure if severe. Pregnant women and their fetuses are particularly at risk.
Leptospirosis is a zoonotic disease caused by Leptospira interrogans bacteria. It has an incubation period ranging from 7-19 days with an average of 10 days. People can contract it through contact with flood waters or soil contaminated by the urine of infected animals like rats. Clinical manifestations include fever, muscle pain, headache, and potentially liver or kidney failure in severe cases. Diagnosis involves examining blood and CSF during the first week or urine on the 10th day. It is treated with antibiotics like penicillin prescribed by a physician.
Stigma & discrimination associated with hivaidsliyew
?
The document discusses stigma and discrimination associated with HIV/AIDS. It defines stigma as a negative attribute that reduces a person's status, and discrimination as unfair treatment based on real or perceived HIV status. Several forms of stigma are outlined, including physical isolation, social exclusion, verbal insults, and institutional barriers like loss of employment or housing. Stigma stems from lack of HIV knowledge and moral judgments about transmission. It can prevent people from seeking testing or care, and undermine prevention and treatment efforts. Addressing HIV-related stigma is important for achieving public health goals.
Malaria is a protozoal disease transmitted through the bites of infected female Anopheles mosquitoes. In 2016, there were an estimated 216 million cases of malaria worldwide, with the majority occurring in Africa. Symptoms vary depending on the Plasmodium species and include fever, chills, and flu-like illness. Diagnosis is typically made through blood smears, antigen testing, or PCR. Treatment involves antimalarial medications such as chloroquine or artemisinin-based combination therapies depending on the species and severity of illness. Prevention strategies include mosquito control measures and chemoprophylaxis for travelers. Drug and insecticide resistance present ongoing challenges to malaria elimination efforts.
The document summarizes information about Ebola virus hemorrhagic fever and Lassa virus hemorrhagic fever. It describes the etiology, epidemiology, signs and symptoms, diagnosis, treatment and prevention of the two viral hemorrhagic fevers. Ebola virus causes a severe multisystem disease in humans characterized by fever, headache and bleeding. Lassa fever is endemic in West Africa and transmitted from rodents to humans, causing fever, bleeding and organ dysfunction. Treatment involves supportive care and the antiviral drug ribavirin.
This document discusses viral hemorrhagic fever (VHF), specifically Lassa fever. It defines VHF and notes that Lassa fever, caused by the Lassa virus, is endemic in parts of West Africa. The virus is transmitted from rodents to humans and then through human contact. Symptoms can range from mild to severe. Diagnosis involves ELISA, PCR and immunohistochemistry. Treatment for Lassa fever involves supportive care and the antiviral drug ribavirin. Prevention focuses on avoiding contact with rodents, proper food storage, hygiene and use of PPE during potential human exposures.
(1) Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Septic shock is persisting hypotension requiring vasopressors and elevated lactate levels despite fluid resuscitation. Organ dysfunction is identified as an acute change in total SOFA score ¡Ý2 points due to infection.
(2) Laboratory diagnosis of sepsis involves blood cultures, biomarkers like PCT, CRP, lactate, cytokines and invasive fungal biomarkers like galactomannan and beta-D-glucan. Hematological parameters and newer techniques like MALDI-TOF and multiplex PCR are also used. Blood cultures remain the gold standard but are often culture negative
Typhoid fever is caused by the Salmonella typhi bacteria and spreads through contaminated food or water. It causes fever and systemic infection. Diagnosis involves blood or stool cultures and serologic testing. Treatment consists of antibiotics like fluoroquinolones for 2 weeks. Prevention involves food and water safety as well as vaccination for travel to areas where typhoid is common.
Dengue fever is a mosquito-borne tropical disease caused by the dengue virus. It is characterized by fever, headache, muscle and joint pains, and a skin rash. Some cases develop into life-threatening dengue hemorrhagic fever or dengue shock syndrome. It occurs widely in tropical areas and an estimated 50 million infections occur annually. The disease progresses through febrile, critical, and recovery phases. During the critical phase, increased capillary permeability can lead to life-threatening plasma leakage and shock.
The document discusses Ebola virus disease (EVD), also known as Ebola hemorrhagic fever. It first appeared in Africa in 1976 and causes severe bleeding and organ failure in humans and nonhuman primates. The virus spreads through direct contact with body fluids of infected individuals or contaminated environments. While there is no approved vaccine or treatment, prevention focuses on isolation of patients, medical staff training in infection control, safe burials, and avoiding contact with high-risk animals like bats that may carry the virus. The document provides details on the virus's pathogenesis, symptoms, subtypes, transmission methods, and the challenges it poses given its rapid multiplication and ability to evade immune responses.
Lassa fever is an acute viral illness endemic to West Africa that is caused by the Lassa virus. It is primarily transmitted to humans via contact with the urine or feces of the multimammate rat, which is the virus's natural host. The presentation outlines key details about the epidemiology, transmission, symptoms, management, and prevention of Lassa fever. Prevention focuses on avoiding contact with infected rats and properly disposing of or sterilizing contaminated items to limit human exposure to the virus.
This newsletter provides information on HIFASS' activities from fiscal year 2015. It discusses HIFASS completing the Safe Pregnancy Project in Benue State, which involved advocacy, identifying and training mentor mothers, peer sessions to mobilize pregnant women for services, and creating community-based organizations. It also summarizes HIFASS' participation in various conferences and meetings with other organizations regarding health initiatives in Africa, including an Ebola vaccine study in Abuja and a scientific training symposium in the US. Finally, it discusses LOPIN-3 organizing a performance review meeting and HIFASS participating in a forum with other CSOs implementing health programs in FCT.
Dengue, Malaria, Chikungunya, Japanese Encephalitis, Pest Control.pptxYuvethaIndran
?
Dengue is a mosquito-borne viral disease caused by the dengue virus. There are four serotypes of the dengue virus. Diagnosis can be made through laboratory tests such as virus isolation, nucleic acid detection through RT-PCR, immunological response tests like ELISA and RDTs, and analysis of hematological parameters. Clinical diagnosis is based on signs and symptoms that present in three phases - febrile, critical, and recovery phase. Common symptoms include high fever, headache, muscle and joint pains, rashes, and bleeding manifestations in severe cases. Laboratory tests aid in diagnosis, screening, monitoring disease severity through platelet count and hematocrit levels.
This document discusses emerging and re-emerging infectious diseases. It begins with an introduction that defines emerging diseases as new diseases caused by newly discovered pathogens, while re-emerging diseases are old diseases that were previously controlled but have risen again as health problems. The document then covers the epidemiology of these diseases, including factors contributing to their emergence such as human behavior, travel, and climate change. Examples are provided of diseases like SARS, Ebola, Zika, and antibiotic-resistant pathogens. Strategies for prevention and the roles of doctors, public health authorities, and public health measures are also outlined.
Rabies is a fatal viral disease transmitted through the bites of rabid animals. It causes tens of thousands of deaths worldwide every year, mostly in Asia and Africa. Dogs are the primary source of transmission to humans. The disease causes neurological symptoms such as anxiety, hydrophobia, and eventually paralysis and death. There is no cure once symptoms appear, making vaccination an important preventative measure.
The coronavirus receives its name from its crown-like appearance under microscopy. Coronaviruses infect the upper respiratory and gastrointestinal tracts in humans, causing about a third of common colds. They have RNA genomes and envelopes derived from host cell membranes. While most cause mild illness, some like MERS-CoV and SARS-CoV can cause severe pneumonia. Person-to-person transmission occurs via respiratory droplets. Basic hygiene and social distancing can help reduce transmission risk. Current risk to the general public is low but some communities face elevated risk where spread is occurring.
#Covid19: Information guide for general Public.MADHUR VERMA
?
This document provides information and guidance on preparing for and responding to the COVID-19 pandemic. It discusses the objectives of preventing transmission, protecting oneself and family, and maintaining a healthy lifestyle during lockdown. It covers the stages of an epidemic, definitions of isolation and quarantine, the nature and transmission of coronavirus, symptoms and diagnosis of COVID-19, treatment, prevention methods like social distancing and hygiene, guidance for high-risk groups, obligations during lockdown, and maintaining mental health.
Zika virus is spread by daytime-active Aedes mosquitoes and often causes mild or no symptoms. It was isolated in Uganda in 1947 and has recently spread to areas in the Americas. The virus is associated with microcephaly in fetuses when the mother is infected during pregnancy and Guillain-Barr¨¦ syndrome in adults. While medications and vaccines are currently unavailable, health organizations recommend precautions for pregnant women such as postponing travel to affected areas.
This document discusses filoviruses, which cause viral hemorrhagic fevers such as Ebola virus disease and Marburg virus disease. It provides background on the classification and transmission of filoviruses, describing how they are spread through contact with bodily fluids. Symptoms are then explained, which include fever, vomiting, and bleeding. As there is no vaccine or cure, treatment focuses on supportive care. The document concludes by reviewing the history of Ebola virus outbreaks since 1976 and discusses current concerns around controlling the ongoing 2014 outbreak in West Africa.
Lassa fever is a viral hemorrhagic illness that occurs in West Africa. It is caused by the Lassa virus and transmitted through contact with infected rodent urine/feces or person-to-person via bodily fluids. Symptoms include fever, general weakness, and bleeding. It is diagnosed through antibody and virus detection tests. Prevention focuses on rodent control and personal hygiene while treatment utilizes the antiviral drug Ribavirin. Lassa fever remains a public health concern in West Africa due to its high mortality rate.
The coronavirus was first detected in Wuhan, China in December 2019. Chinese authorities confirmed it was a new coronavirus called 2019-nCoV. Coronaviruses can cause illnesses ranging from the common cold to more severe diseases like SARS. Prevention methods include frequent hand washing, coughing into the elbow, avoiding contact with sick people, and thoroughly cooking animal products. The virus causes respiratory failure and in some cases brain infection, with death resulting primarily from respiratory failure. It spreads through respiratory secretions like coughing and sneezing. Diagnosis involves laboratory tests on respiratory specimens and blood. Some potential treatments showing effectiveness include protease inhibitors and interferon.
Monkeypox is caused by monkeypox virus, an orthopoxvirus. It occurs sporadically in parts of Central and West Africa. Symptoms include fever, headache, lymphadenopathy and a rash that starts on the face and spreads to other parts of the body. It is usually self-limiting but can be serious in children or immunocompromised individuals. Diagnosis involves collecting samples from lesions for laboratory testing. There is no specific treatment but smallpox vaccination provides protection. Prevention focuses on reducing exposure to infected animals or contact with infected humans.
Impact of infectious diseases As people know, now the COVID-1.docxcharisellington63520
?
Impact of infectious diseases
As people know, now the COVID-19 is quite serious and spreading rapidly. And people do not have a curing method about it. COVID-19 causes xxx confirmed diagnosis and xxx death in the whole world. Also, people still don't know where COVID-19 comes from and how we can protect ourselves from being healthy. From COVID-19, people should have profound thinking about why infection diseases cause and how can human avoid virus infection and how can government-run do during the virus outbreak and reconstruction after the outbreak. Historically, there are so many infection diseases in the world, such as SARAS, Ebola, HIV and COVID-19.
Most infectious diseases are caused by microorganisms, such as bacteria, viruses, parasites, or fungi. Diseases can be spread from person to person, directly or indirectly. Zoonotic diseases are infectious diseases of animals that can cause diseases when spread to humans. However, infectious diseases are caused by multiple reasons, mostly infectious is from animals, because some animals they carry the virus in their body, those viruses may not affect themselves, however, when spreading of the virus, the virus will mutate to parasitize humans, and human's body will have an overt reaction to the virus. In this article, it will discuss 4 infectious diseases, SARAS, HIV, Ebola, and COVID-19.
In the first place, whenever someone always have doubts where infectious diseases from, how infectious diseases are formed. ÆÕ±éÉÏÀ´Ëµ£¬Infectious diseases usually have a great harm rate, because when an infectious disease breaks out, the doctors usually do not have any preparations, so they can not treat the disease well, or sometimes they can infect the doctor themselves. If people want to protect them in order to avoid disease, the most considerable thing is that they must know least one infectious history, such as how it formed, who is more susceptible to infection, does it have any medical treatment, does it success. SARAS is a typical example about it. Practically, SARS-CoV is the severe acute respiratory syndrome coronavirus, and it is deadly infectious diseases and people are also easily infected. SARS- CoV cause 8096 cases, including 774 deaths, in 37 countries for 8 months. The transmit speed of SRAS is very fast, people who get infection, they always have Fever, cough, difficulty breathing, chest radiographs showing shadows of both lungs, and some patients developed respiratory failure. Unfortunately, the use of antibiotics against bacterial infections has not worked. And SRAS infectious for people is depend on the strength of the personal resistance occurs. From research, SRAS-CoV's occurrence of spreading in wild animals. Because the scientist are aware of SRAS virus related to the spread of wild animals. Following this clue, the scientists first targeted the Guangdong wildlife market, and soon isolated and detected exactly the same virus as the SARS virus in the civet cats on the market..
Selected Definition in Infectious Disease Epidemiology & Uses.pptxDr. Anuj Singh
?
1. Epidemiology is defined as the study of the distribution and determinants of health-related states or events in specified populations and the application of this study to control relevant health problems.
2. Key components of epidemiology include measuring disease frequency and distribution, and identifying determinants and risk factors of diseases. Infectious disease epidemiology studies topics such as infection, contamination, infestation, and the definitions of an infectious disease.
3. Epidemiology is useful for community diagnosis, disease surveillance, planning and evaluation of health programs, and identifying risk factors and the natural history of diseases.
This document summarizes information about dengue, a mosquito-borne viral infection. It discusses the global incidence and distribution of dengue, noting that incidence has increased in recent decades. Dengue symptoms and the different forms it can take are described. Treatment involves symptom relief and fluid maintenance. Vaccines have been developed but have limitations. Prevention relies on controlling mosquito populations and limiting their habitats. Global and national strategies aim to reduce dengue burden through prevention, control programs, and surveillance.
MONKEY POX PUBLIC HEALTH EMERGENCY OF CONCERNRenu Bedi
?
Introduction, Historic Background, Global scenario, Case definition, Clinical feature, diagnosis, clinical and preventive management and surveillance strategy
Infectious diseases (cholera, TB, malaria, HIV AIDS)Maria Shuaib
?
This document discusses infectious diseases including cholera, malaria, tuberculosis, and HIV/AIDS. It defines infectious diseases as those that can be passed between people through pathogens like viruses, bacteria, or fungi. For each disease, it describes the causative agent, mode of transmission, treatment, prevention, and impact. Key facts provided include that cholera is caused by Vibrio cholerae bacteria spread through contaminated food or water, malaria by Plasmodium parasites transmitted by mosquitoes, HIV/AIDS is a retrovirus that destroys immune cells, and tuberculosis is caused by Mycobacterium transmitted through air. Prevention strategies like vaccines, improved hygiene and access to treatment are discussed.
Smallpox is a deadly infectious disease caused by the variola virus that was declared eradicated worldwide in 1980 through a global vaccination program. It is characterized by a high fever and distinctive skin rash. While two labs currently house samples of the virus, concerns remain that it could be used in a bioterrorism attack given some countries may still have undeclared stockpiles. The only known effective prevention is vaccination with the vaccinia vaccine within a few days of exposure, though supplies are currently insufficient for a large-scale outbreak.
Ronald Ross and Charles Louis Alphonse Laveran made early discoveries about malaria transmission. Ross demonstrated in 1897 that malaria parasites could be transmitted from infected patients to mosquitoes, while Laveran first observed parasites in the blood of malaria patients in 1880. Malaria remains a major public health problem in parts of India, especially in the northeastern states, with P. falciparum and P. vivax the predominant species. In Andaman and Nicobar Islands, a study from 2010-2016 found over 8,000 confirmed malaria cases, though the annual parasite incidence declined over this period. Prevention strategies for malaria include indoor residual spraying, insecticide-treated bed nets, larval control, chemoprophylaxis, and
2. OUTLINE
? INTRODUCTION
? THE VIRUS
? THE RAT
? TRANSMISSION
? DISTRIBUTION
? SYMPTOMS AND SIGNS
? DIAGNOSIS
? TREATMENT
? PREVENTION
? CONCLUSION2/1/2016 2
3. INTRODUCTION
? Lassa fever is an acute viral illness that occurs in
west Africa.
? The illness was discovered in 1969 when two
missionary nurses died in Nigeria.
? The virus is named after the town-LASSA, IN
BORNU STATE in Nigeria where the first cases
occurred.
? These cases were from two missionary health
workers who died from contacts with ill persons.
2/1/2016 3
4. THE VIRUS
? The virus, a member of the virus family
Arenaviridae, is a single-stranded RNA virus and is
zoonotic, or animal-borne.
? Viral hemorrhagic fevers (VHFs) are caused by
several families of enveloped RNA
viruses: filoviruses (Ebola and Marburg hemorrhagic
fever), arenaviruses (Lassa fever, Lujo, Guanarito,
Machupo, Junin, Sabia, and Chapare viruses),
bunyaviruses (Rift Valley fever [RVF], Crimean-
Congo hemorrhagic fever [CCHF], and
hantaviruses), and flaviviruses (dengue, yellow
fever, Omsk hemorrhagic fever, Kyasanur Forest
disease, and Alkhurma viruses)2/1/2016 4
6. THE RAT
THE FRIEND ADDIND TO BLOOD THEN THE MONSTER PUSHING BLLOD OUT2/1/2016 6
7. THE RAT...
? The reservoir, or host, of Lassa virus is a rodent known
as the "multimammate rat" (Mastomys natalensis).
? Once infected, this rodent is able to excrete virus in
urine for an extended time period, maybe for the rest
of its life.
? Mastomys rodents breed frequently, produce large
numbers of offspring, and are numerous in the
savannas and forests of west, central, and east Africa.
In addition, Mastomys readily colonize human homes
and areas where food is stored. All of these factors
contribute to the relatively efficient spread of Lassa
virus from infected rodents to humans.2/1/2016 7
8. TRANSMISSION
? Transmission of Lassa virus to humans occurs most
commonly through ingestion or inhalation.
? Mastomys rodents shed the virus in urine and
droppings and direct contact with these materials,
through touching soiled objects, eating contaminated
food, or exposure to open cuts or sores, can lead to
infection. Because Mastomys rodents often live in and
around homes and scavenge on leftover human food
items or poorly stored food, direct contact
transmission is common.
? Mastomys rodents are sometimes consumed as a food
source and infection may occur when rodents are
caught and prepared.2/1/2016 8
9. TRANSMISSION...
? Contact with the virus may also occur when a
person inhales tiny particles in the air contaminated
with infected rodent excretions. This aerosol or
airborne transmission may occur during cleaning
activities, such as sweeping.
? Direct contact with infected rodents is not the only
way in which people are infected; person-to-person
transmission may occur after exposure to virus in
the blood, tissue, secretions, or excretions of a
Lassa virus-infected individual.
2/1/2016 9
10. TRANSMISSION...
? Casual contact (including skin-to-skin contact
without exchange of body fluids) does not spread
Lassa virus.
? Person-to-person transmission is common in
health care settings (called nosocomial
transmission) where proper personal protective
equipment (PPE) is not available or not used.
? Lassa virus may be spread in contaminated medical
equipment, such as reused needles.
2/1/2016 10
11. DISTRIBUTION
? Lassa fever is endemic in parts of west Africa
including Sierra Leone, Liberia, Guinea and
Nigeria.
? However, other neighboring countries are also at
risk, as the animal vector for Lassa virus, the
"multimammate rat" (Mastomys natalensis) is
distributed throughout the region.
2/1/2016 11
12. DISTRIBUTION...
? In 2009, the first case from Mali was reported in a
traveler living in southern Mali; Ghana reported its
first cases in late 2011.
? Isolated cases have also been reported in C?te
d¡¯Ivoire and Burkina Faso and there is serologic
evidence of Lassa virus infection in Togo and Benin.
2/1/2016 12
13. DISTRIBUTION...
? The number of Lassa virus infections per year in
west Africa is estimated at 100,000 to 300,000,
with approximately 5,000 deaths.
? Unfortunately, such estimates are crude, because
surveillance for cases of the disease is not
uniformly performed.
2/1/2016 13
14. DISTRIBUTION...
? In some areas of Sierra Leone and Liberia, it is
known that 10%-16% of people admitted to
hospitals every year have Lassa fever, which
indicates the serious impact of the disease on
the population of this region.
2/1/2016 14
17. DISTRIBUTION...
? Lassa fever is endemic in Nigeria and causes
outbreaks almost every year in different parts of the
country, with yearly peaks observed between
December and February.
? The case-fatality rate in hospitalized px is10%¨C20%.
? Investigations in the 1970s and 1980s pointed to
the existence of 3 disease-endemic zones within
Nigeria: the NE region around Lassa, the central
region around Jos, and the southern region around
Onitsha.
2/1/2016 17
18. DISTRIBUTION...
? From 2005 through 2008, 10 cases of Lassa fever
were confirmed by virus detection
? Cases 7 to 10 occurred in Abuja and Jos from
December 2007 through March 2008
? Between August 2015 and 23 January 2016, 159
suspected cases of Lassa fever, including 82 deaths,
were reported across 19 states.
? Investigations are ongoing and a retrospective
review of cases is currently being performed;
therefore, these figures are subject to change.
2/1/2016 18
19. DISTRIBUTION...
? The 4 most affected states are Bauchi, Edo, Oyo and
Taraba, which account for 54% of the confirmed
cases (n=54) and 52% of the reported deaths
(n=34). The remaining 15 States have reported less
than 5 confirmed cases.
? Samples of 54 cases, including 34 deaths, were
confirmed for Lassa fever by reverse transcription
polymerase-chain reaction (RT-PCR). All samples
tested negative for Ebola virus disease, Dengue and
yellow fever.
2/1/2016 19
20. DISTRIBUTION...
? To date, 4 health care workers were
laboratory-confirmed for Lassa fever; of these
4 cases, 2 passed away.
? As of 21 January, 2,504 contacts had been
listed and 1,942 are currently being
monitored.
? A total of 562 contacts have completed follow
up. So far, none of the contacts have tested
positive for Lassa fever.
2/1/2016 20
21. DISTRIBUTION...
? Another report says:On 14 January, official records
states at least 140 suspected cases and 30
confirmed cases, including 53 deaths, in 14 states
indicating a case fatality rate of 37.9%
? As of 20 January, local media has reported as many
as 212 suspected cases and 63 deaths in 17 states.
? The number of suspected cases of Lassa fever has
reached 212 across 17 states, the Minister of Health
confirmed. As of 19 January, there were 76
fatalities.
2/1/2016 21
24. SYMPTOMS AND SIGNS
? Signs and symptoms of Lassa fever typically occur
1-3 weeks after the patient comes into contact
with the virus.
? For the majority of Lassa fever virus infections
(approximately 80%), symptoms are mild and are
undiagnosedMild symptoms include slight fever,
general malaise and weakness, and headache.
2/1/2016 24
25. SYMPTOMS AND SIGNS...
? In 20% of infected individuals, however, disease
may progress to more serious symptoms including
respiratory distress, repeated vomiting, facial
swelling, pain in the chest, back, and abdomen.
? More severe symptoms include: diarrhoea,bleeding
(from eyes, nose, mouth(gums), anus, vaginal,
pennis).
? Pulmonary oedema, encephalitis, hearing loss and
shock(loss of consciousness).
2/1/2016 25
27. DIAGNOSIS
? Lassa fever is most often diagnosed by using enzyme-
linked immunosorbent serologic assays (ELISA), which
detect IgM and IgG antibodies as well as Lassa
antigen.
? Reverse transcription-polymerase chain reaction (RT-
PCR) can be used in the early stage of disease.
? The virus itself may be cultured in 7 to 10 days, this
procedure should only be done in a high containment
laboratory with good laboratory practices.
? Immunohistochemistry, performed on formalin-fixed
tissue specimens, can be used to make a postmortem
diagnosis.2/1/2016 27
28. TREATMENT
? It is better when detected early
? Supportive care is with fluid, treatment of
symptoms and Oxygen therapy.
? Ribavirin is the anti-viral agent which has been
shown to be most effective when given early in the
course of the illness.
? Effective management of the complications is
important.
2/1/2016 28
29. PREVENTION
? Primary transmission of the Lassa virus from its
host to humans can be prevented by avoiding
contact with Mastomys rodents, especially in the
geographic regions where outbreaks occur.
? Putting food away in rodent-proof containers and
keeping the home clean help to discourage
rodents from entering homes.
2/1/2016 29
30. PREVENTION...
? Using these rodents as a food source is not
recommended.
? Trapping in and around homes can help
reduce rodent populations;
? However, the wide distribution of Mastomys
in Africa makes complete control of this
rodent reservoir impractical.
2/1/2016 30
31. PREVENTION...
? When caring for patients with Lassa fever, further
transmission of the disease through person-to-
person contact or nosocomial routes can be
avoided by taking preventive precautions against
contact with patient secretions (called VHF
isolation precautions or barrier nursing methods).
2/1/2016 31
32. PREVENTION...
? Such precautions include wearing personal
protective equipment (PPE): protective clothing,
such as masks, gloves, gowns and goggles and
safety shoes
? Using infection control measures, such as complete
equipment sterilization Isolating infected patients
from contact with unprotected persons until the
disease has run its course.
2/1/2016 32
33. CONCLUSION
? The rat is a palatable meal particularly among
the resource poor population: a friend
? It carries a deadly virus which is responsible for
tension, illness and death among Nigerians and
other West African countries: a foe.
? It is sad to lose a palatable meal to a rat but
sadder when loved ones lose you to a rat.
2/1/2016 33